Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit

Medroxyprogesterone/MP ELISA Kit

Catalog #:   KSK61601 Specific References (50) DATASHEET
Sample type: Plasma, Serum, Urine
Sensitivity: 0.5 ng/mL
Range: 1.56 - 100 ng/mL
Overview

Catalog No.

KSK61601

Detection method

Colorimetric

Sample type

Plasma, Serum, Urine

Assay type

Quantitative (Competitive)

Range

1.56 - 100 ng/mL

Sensitivity

0.5 ng/mL

Precision

CV<15%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

PREGN-4-ENE-3,20-DIONE,17-HYDROXY-6-ALPHA-METHYL-;17伪-Hydroxy-6伪-methyl-4-pregnene-3,20-dione,17伪-Hydroxy-6伪-methylprogesterone,6伪-Methyl-5-pregnen-17伪-ol-3,20-dione,6-Dihydromegestrol;(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;(6S,8R,9S,10R,13S,14S,17R)-17-ethanoyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;4-Pregnen-6a-Methyl-17-ol-3,20-dione-d7;(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-triMethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;Medroxyprogesteroneacetate-13C2-d3;6alpha-Methyl-17alpha-hydroxypregn-4-ene-3,20-dione

Data Image
References

CYPD limits HR+ mammary carcinogenesis in mice., PMID:40494873

Hormonal contraception for women at risk of HIV infection., PMID:40476466

Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort., PMID:40470656

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma., PMID:40458122

Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria., PMID:40453650

The Follicular Output Rate was Improved with 3-Day Letrozole Administration Compared with 5-Day Letrozole Administration Under Progestin-Primed Ovarian Stimulation., PMID:40453208

Progestin-only contraception and thrombosis: an updated systematic review., PMID:40451566

Use of calibrated filter paper to evaluate vaginal moisture in mice., PMID:40447658

Serum concentrations of medroxyprogesterone acetate were undetectable on OPU+5 days and had no effect on the serum progesterone level in patients undergoing the progestin-primed ovarian stimulation protocol., PMID:40438399

Effects of Hormone Replacement Treatment with Estrogen and Progestins on the Vascular Renin-Angiotensin System of Ovariectomized Rats., PMID:40430069

Menstrual Dysphoria and Preferences for Menstrual Suppression in Transgender and Gender-Diverse Youth., PMID:40425108

Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin-Resistant Endometrial Cancer Cells., PMID:40415233

A systematic comparison of implementation strategies at three U.S. clinic settings that expanded access to self-administered injectable contraception., PMID:40414479

Progestin prime ovarian stimulation provides comparable outcomes to GnRH antagonist in donor cycles with vitrified oocytes., PMID:40403912

Addressing the Social Determinants of Health in the Amazon River Communities of Loreto, Peru, to Improve Maternal Health Access., PMID:40400855

Euploidy rate and pregnancy outcomes in preimplantation genetic testing for aneuploidy cycles using progestin-primed ovarian stimulation versus GnRH antagonist protocol., PMID:40382646

Progestogens in Menopausal Hormone Therapy: A Double-Edged Sword., PMID:40378875

Depot medroxyprogesterone acetate (DMPA)-associated early-onset osteoporotic fracture., PMID:40372778

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells., PMID:40371351

Peripheral precocious puberty in girls with McCune-Albright syndrome: a case series., PMID:40366083

Paradoxical evolution of spheno-orbital meningioma after cessation of progestin treatment., PMID:40353175

Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients., PMID:40350707

Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 Acquisition., PMID:40349359

Chronic Mountain Sickness: A Comprehensive Review of Current Management and Proposals for Novel Therapies., PMID:40329926

Therapeutic Options for Unscheduled Bleeding on Hormonal Contraception., PMID:40320274

Characteristics and Preoperative Management of Adolescent Patients with Pathology-Confirmed Endometriosis: A Multi-Institutional Study., PMID:40318750

Comparison of Assisted Reproductive Technology (ART) Outcomes in Two Controlled Ovarian Stimulation Protocols Using Follitropin Delta, a Recombinant Follicle-Stimulating Hormone (rFSH) Injection., PMID:40291328

Treatment With a Nonaromatizable Androgen for Transgender Man With a Hormone-sensitive Ovarian Cancer., PMID:40271001

Pharmacokinetic and clinical associations between doravirine-containing ART and injectable and implantable hormonal contraceptive methods among women living with HIV in South Africa., PMID:40261052

Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives., PMID:40260892

Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate., PMID:40242009

Steroid-Modulated Transcription Synergistically Forms DNA Double-Strand Breaks With Topoisomerase II Inhibitor., PMID:40231641

Medroxyprogesterone acetate and meningioma: a global issue., PMID:40207201

Understanding and treating menstruation associated sickle cell pain., PMID:40181434

Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women living with HIV on efavirenz: a prospective cohort study., PMID:40176530

Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures., PMID:40175633

The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials., PMID:40170070

Synchronous Endometrial and Ovarian Adenocarcinomas in a 43-Year-Old Patient Following Infertility Treatment: A Case Report., PMID:40150013

Primary Low-Grade Endometrial Stromal Sarcoma of the Ovary Arising From Endometriosis: A Case Report., PMID:40144425

Fertility-Sparing Treatments in Endometrial Cancer: A Comprehensive Review on Efficacy, Oncological Outcomes, and Reproductive Potential., PMID:40142282

Progestin Pollution in Surface Waters of a Major Southwestern European Estuary: The Douro River Estuary (Iberian Peninsula)., PMID:40137552

Insights into breeding management and contraception in catteries - What we learned from an online survey., PMID:40081001

Efficacy and safety of medroxyprogesterone acetate on noninvasive ventilation -treated exacerbated COPD patients: a double-blind randomized clinical trial., PMID:40065288

Leukocytosis Associated With Medroxyprogesterone in Gender-Affirming and Fertility Treatments., PMID:40062147

Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial., PMID:40059192

Effects of hCG administered 5 or 7 days after the onset of induced estrus on luteal morphology and function in seasonally anovular dairy goats., PMID:40057995

Effect of Nigella sativa-L supplementation on glycemia in adolescent polycystic ovarian syndrome: secondary analysis of a randomized controlled trial study., PMID:40055705

How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria., PMID:40038661

Co-Estimating Estradiol Valerate and Medroxyprogesterone Acetate in a Combined Hormonal Product: A Novel Short Runtime UPLC Method., PMID:40036759

Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus., PMID:40021110

Datasheet
$ 750
Product specifications
96 T 750

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Medroxyprogesterone/MP ELISA Kit [KSK61601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only